Professional business directory

Find the best businesses and services near you. Discover verified companies across all industries.

Category: chemotherapy

chemotherapy Oct 16

OPTIMAL CONTROL OF DRUG ADMINISTRATION IN CANCER CHEMOTHERAPY - MARTIN R ET AL

AUTHOR AFFILIATION : DSTO, SOUTH AUSTRALIA PUB DATE : 24-Nov-93 ONLINE RELEASE DATE : 10-Mar-1

View Details
chemotherapy Feb 04

Essai clinique - PIPAC ESTOK 01 - EVENO Clarisse - AP-HP - Hôpital Lariboisiere-Fernand Widal

Essai clinique - PIPAC ESTOK 01 Acronyme : PIPAC ESTOK 01 Investigateur coordonnateur : EVENO

View Details
chemotherapy Feb 04

Essai clinique - MYECHILD01 - LEVERGER Guy - AP-HP - Hôpital Armand Trousseau-La Roche Guyon

Essai clinique - MYECHILD01 Acronyme : MYECHILD01 Investigateur coordonnateur : LEVERGER Guy

View Details
chemotherapy Feb 04

Essai clinique - TRANSMET - ADAM Rene - AP-HP - Hôpital Paul Brousse

Essai clinique - TRANSMET Acronyme : TRANSMET Investigateur coordonnateur : ADAM Rene Centr

View Details
chemotherapy Mar 31

Etablissement Université de Biskra - Mohamed Khider Affiliation Département des Sciences Nature et de la vie Auteur BELLEBCIR, Leila Directeur

Mémoires de Fin d’Etudes Etablissement Université de Biskra - Mohamed Khider Affiliation Départeme

View Details
chemotherapy Sep 18

TRISENOX 1 MG/ML INJ AMP 10 ML (Arsenic trioxide)

TRISENOX 1 MG/ML INJ AMP 10 ML (Arsenic trioxide) - Maladie rare sans désignation orpheline Induc

View Details
chemotherapy Sep 18

VELCADE 1 MG INJ FL (Bortezomib)

VELCADE 1 MG INJ FL (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy or in

View Details
chemotherapy Sep 18

VELCADE 3,5 MG INJ FL 1 (Bortezomib)

VELCADE 3,5 MG INJ FL 1 (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy o

View Details
chemotherapy Sep 18

MABTHERA 100 MG PERF FL 10 ML (Rituximab)

MABTHERA 100 MG PERF FL 10 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
chemotherapy Sep 18

MABTHERA 500 MG PERF FL 50 ML (Rituximab)

MABTHERA 500 MG PERF FL 50 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
chemotherapy Sep 18

ERBITUX 2 MG/ML INJ FL 50 ML (Cetuximab)

ERBITUX 2 MG/ML INJ FL 50 ML (Cetuximab) - Maladie rare sans désignation orpheline Treatment of p

View Details
chemotherapy Sep 18

ERBITUX 5 MG/ML PERF FL 100 ML (Cetuximab)

ERBITUX 5 MG/ML PERF FL 100 ML (Cetuximab) - Maladie rare sans désignation orpheline Treatment of

View Details